Eton Pharmaceuticals Revenue and Competitors

Deer Park, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Eton Pharmaceuticals's estimated annual revenue is currently $8.8M per year.(i)
  • Eton Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Eton Pharmaceuticals has 44 Employees.(i)
  • Eton Pharmaceuticals grew their employee count by 7% last year.

Eton Pharmaceuticals's People

NameTitleEmail/Phone
1
Sr. VP, Quality and OperationsReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP, Regulatory Affairs at Eton PharmaceuticalsReveal Email/Phone
4
VP FinanceReveal Email/Phone
5
SVP, Regulatory Affairs & Technical ServicesReveal Email/Phone
6
VP, Sales & MarketingReveal Email/Phone
7
Senior Director, Medical AffairsReveal Email/Phone
8
Sr. Director Project ManagementReveal Email/Phone
9
Chief Business OfficerReveal Email/Phone
10
Marketing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is Eton Pharmaceuticals?

Eton Pharmaceuticals, Inc. is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. Our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$8.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eton Pharmaceuticals News

2022-04-06 - Eton Pharmaceuticals Announces FDA Approval of Cysteine ...

Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The...

2022-04-06 - Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

DEER PARK, Ill., April 11, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused...

2022-04-06 - FDA approves Eton Pharmaceuticals' cysteine hydrochloride ...

Eton's drug is a bioequivalent generic of Exela Pharma Sciences' Elcys, which the FDA approved in 2019. The FDA granted Eton 180 days of generic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.5M4410%N/A
#2
$10.2M442%N/A
#3
$35M484%N/A
#4
$11.4M49-9%N/A
#5
$10.1M5014%N/A